Dr Reddy’s launches world's 1st immuno-onco drug for nasopharyngeal cancer in India
Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.
Zacks.com on MSN4d
RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal Carcinoma
Dr. Reddy’s Laboratories RDY announced that it has launched a biosimilar of Coherus BioSciences’ CHRS Loqtorzi (toripalimab) ...
Medindia2d
Dr. Reddy's Launches Toripalimab in India for Nasopharyngeal Carcinoma Treatment
Dr. Reddy's Laboratories launches Toripalimab in India, a groundbreaking treatment for metastatic and recurrent ...
Dr. Reddy's up 2% on launching Toripalimab to treat nasopharyngeal cancer
In 2023, Dr. Reddy's entered into a license and commercialisation agreement with Shanghai Junshi Biosciences Co. Ltd for ...
Dr Reddy's launches Toripalimab to treat nasopharyngeal cancer in India
In 2023, Dr Reddy's signed a licensing and commercialisation agreement with Shanghai Junshi Biosciences for Toripalimab ...
The Financial Express6d
Dr. Reddy’s launches first immuno-oncology drug to treat rare form of head and neck cancer in India
Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the ...
"metastatic-nasopharyngeal-carcinoma-rm-npc"
News on Telangana Today, Metastatic nasopharyngeal carcinoma (RM-NPC) latest news, Metastatic nasopharyngeal carcinoma (RM-NPC) news, | Telangana Today ...
Cancer drug Toripalimab that treats aggressive form of head and neck cancer launched in India
Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Only immuno-oncology drug approved by various regulatory authorities around the world such as the USFDA, DCGI, EMA, MHRA, ...
Business Line6d
Dr Reddy’s launches nasopharyngeal carcinoma drug Toripalimab in India
“The launch of Toripalimab is a significant milestone for patients diagnosed with nasopharyngeal carcinoma (NPC) in India.
Dr Reddy's launches cancer drug Toripalimab in India
In 2023, Dr Reddy's signed a licensing and commercialization agreement with Shanghai Junshi Biosciences for Toripalimab which ...
Dr. Reddy's Launches Toripalimab For Nasopharyngeal Carcinoma In India
Dr. Reddy's Laboratories Ltd. (RDY) said that it has launched Toripalimab in India, the first and only immuno-oncology drug approved ...